AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

Search

Oxford Biomedica PLC

Slēgts

334 -0.6

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

332

Max

342.5

Galvenie mērījumi

By Trading Economics

Ienākumi

22M

-11M

Pārdošana

27M

78M

Peļņas marža

-13.726

Darbinieki

850

EBITDA

25M

5M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+87.57% upside

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

40M

348M

Iepriekšējā atvēršanas cena

334.6

Iepriekšējā slēgšanas cena

334

Oxford Biomedica PLC Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 5. jūn. 20:45 UTC

Peļņas

Broadcom 2Q Sales Climb on Booming AI Demand

2025. g. 5. jūn. 23:45 UTC

Tirgus saruna

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

2025. g. 5. jūn. 23:44 UTC

Tirgus saruna

Gold Edges Higher on Weak U.S. Data -- Market Talk

2025. g. 5. jūn. 23:30 UTC

Tirgus saruna

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

2025. g. 5. jūn. 21:32 UTC

Peļņas

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025. g. 5. jūn. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 5. jūn. 20:45 UTC

Peļņas

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025. g. 5. jūn. 20:24 UTC

Peļņas

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025. g. 5. jūn. 20:15 UTC

Peļņas

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

2025. g. 5. jūn. 20:15 UTC

Peļņas

Broadcom 2Q Rev $15B >AVGO

2025. g. 5. jūn. 20:15 UTC

Peļņas

Broadcom 2Q Net $4.97B >AVGO

2025. g. 5. jūn. 20:15 UTC

Peļņas

Broadcom 2Q Adj EPS $1.58 >AVGO

2025. g. 5. jūn. 20:15 UTC

Peļņas

Broadcom 2Q EPS $1.03 >AVGO

2025. g. 5. jūn. 20:15 UTC

Peļņas

Broadcom Sees 3Q Rev $15.8B >AVGO

2025. g. 5. jūn. 20:11 UTC

Iegādes, apvienošanās, pārņemšana

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

2025. g. 5. jūn. 20:11 UTC

Iegādes, apvienošanās, pārņemšana

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

2025. g. 5. jūn. 20:11 UTC

Iegādes, apvienošanās, pārņemšana

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

2025. g. 5. jūn. 19:22 UTC

Tirgus saruna

Oil Futures Resume Upward Moves -- Market Talk

2025. g. 5. jūn. 19:00 UTC

Tirgus saruna

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

2025. g. 5. jūn. 18:32 UTC

Tirgus saruna

Gold Slips After Trump-Xi Call -- Market Talk

2025. g. 5. jūn. 18:26 UTC

Peļņas

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

2025. g. 5. jūn. 18:06 UTC

Tirgus saruna

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

2025. g. 5. jūn. 16:30 UTC

Iegādes, apvienošanās, pārņemšana

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

2025. g. 5. jūn. 16:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 5. jūn. 16:18 UTC

Tirgus saruna

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

2025. g. 5. jūn. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 5. jūn. 16:12 UTC

Tirgus saruna

Global Energy Roundup: Market Talk

2025. g. 5. jūn. 16:12 UTC

Tirgus saruna

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

2025. g. 5. jūn. 16:03 UTC

Tirgus saruna

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

2025. g. 5. jūn. 15:49 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Oxford Biomedica PLC Prognoze

Cenas mērķis

By TipRanks

87.57% augšup

Prognoze 12 mēnešiem

Vidējais 649.002 GBX  87.57%

Augstākais 798.369 GBX

Zemākais 498.981 GBX

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Oxford Biomedica PLC — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

2 ratings

2

Pirkt

0

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Oxford Biomedica PLC

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.